The author would like to issue an erratum for this article [1], and would like to declare the following competing interests which were inadvertently missed in the original publication.
Competing interests
I declare that I worked as an external freelance scientific consultant for Fresenius Kabi in Chile. My work has been limited to bibliographical analysis in the metabolic field non related with clinical practice. I have not endorsed products of Fresenius Kabi company, particularly Dipeptiven.
Footnotes
The online version of the original article can be found under doi:10.1186/s13054-015-1175-3.
Reference
- 1.Leguina-Ruzzi A. A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition. Critical Care. 2016;20:7. doi: 10.1186/s13054-015-1175-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
